Tag Archives: MJN

Mead Johnson Nutrition Company (MJN)

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, Latin America and Europe.

News about MJN

This Is Why The Venezuela Cryptocurrency Matters
&l;p&g;Fiat digital coins are coming. And the concept is just as clunky as the name.This week, President Trump banned deals in the Venezuela Petro, a cryptocurrency backed by crude oil.The Petro speaks volumes about Venezuelan finances. It also sound...Read More>>>

What I Learned About Bitcoin Could Make You A Fortune...
When I was first asked to write a book about bitcoin, the price was hovering at about $3,000. As part of my research, I bought a little. By the time the book was finished, which was really only a matter of weeks, the price had risen to just a tad ove...Read More>>>

Did You Just Miss the Launch of the U.S. Listed Marijuana ETF?
The first trading session after Christmas is almost a quiet trading session, and the market is likely to remain quiet until after the start of 2018. The news flow from companies just is not usually that strong. One exception has been in the legaliza...Read More>>>

GW Pharmaceuticals Q4 Earnings: Waiting on an NDA Decision
UK based small cap cannabinoid stock GW Pharmaceuticals PLC (NASDAQ: GWPH) reported Q4 2017 earnings before the market opened on Monday. Revenue for the twelve months ended September 30th was £8.2 million ($11.0 million) versus £10.3 million for ...Read More>>>

Market Cycles Point Towards A Down Week For Stocks
Summary: ·       The S&P 500 moved higher last week, rising by 0.9%. ·       Uncertainty in Europe ticked up, as Angela Merkel’s attempt to form a coalition governmen...Read More>>>